A micromethod for measuring 17a-hydroxyprogesterone in blo’od collected on filter paper has been developed. Our method is rapid, easy and has the specificity, accuracy and precisoin of the radioimmunoassay in whole blood. The method has been applied for screening patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Fifty samples collected on filter paper were assayed by our method, using 1251 as tracer, and results were compared with those obtained for the same samples using a tritium tracer. The agreement between the two methods was particularly good in the area ranging from 15 to 100 pg/disc. In one neonate the diagnosis of CAH was made utilizing the microfilter paper method. Our method is a promising screening test for CAH. An indication of the advantages or disadvantages of this type of screening will become available when an adequate number of infants has been examined.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Bongiovanni A.M., Eberlein W.R. Defective steroidal biogenesis in congenital adrenal hyperplasia. Pediatrics 21: 661, 1958.
Bongiovanni A.M., Root A.W. The adrenogenital syndrome. N. Engl. J. Med. 268: 1283, 1963.
Sinopoulos A.P., Marshall J.R., Delea C.S., Bartter F.C. Studies on the deficiency of 21 -hydroxylation in patients with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 32: 438, 1971.
Childs B., Grumbach M.M., Van Wyk J.J. Virilizing adrenal hyperplasia: a genetic and hormonal study. J.Clin. Invest. 35: 213, 1956.
Prader A., Anders J.G., Habich H. Zur genetik des kongenitalen adrenogenitalen syndrome. Helv. Paediatr. Acta 77: 271, 1962.
Qazi Q.H., Thompson M.W. Incidence of salt losing form of congenital virilizing adrenal hyperplasia. Arch. Dis. Child. 47: 302, 1972.
Rosembloom A.L, Smith P.V. Congenital adrenal hyperplasia. Lancet 1: 660, 1966.
Hirschfeld A.J., Fleshman J.K. An unusually high incidence of salt losing congenital adrenal hyperplasia in the Alaskan Eskimo. J. Pediatr. 75:492, 1969.
Pang S., Hotchkiss J., Drash A.L., Levine L.S., New M.I. Microfilter paper method for 17-a-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 45: 1003, 1977.
Shackleton C.H., Mitchell F.L., Farquhar J.W. Difficulties in the diagnosis of adrenogenital syndrome in infancy. Pediatrics 49: 198, 1972.
Youssefnejadian E., David R. Early diagnosis of congenital adrenal hyperplasia by measurement of 17-a-hydroxyprogesterone. Clin. Endocrinol. (Oxf.) 4: 451, 1975.
Lippe B.M., La Franchi S.H., Lavin N., Parlow A., Coyotupa J., Kaplan S.A. Serum 17-a-hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia. J. Pediatr. 85: 782, 1974.
Milunsky A., Tulchinsky D. Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 59: 768, 1977.
Hughes I.A., Winter J.S.D. The application of a serum 17-α-OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia. J. Pediatr. 88: 766, 1976.
Bacon G.E., Kelch R.P. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a review of current knowledge. J. Endocrinol. Invest. 2: 93, 1979.
Hunter W.M., Nars P.W., Rutheford F.J. Preparation and behavior of 125I-labelled radioligands for phenolic and neutral steroids. J. Endocrinol. 57: 48, 1973.
Supported by grant no. 0T79.00965.04 01 CNR.
About this article
Cite this article
Piazzi, S., Capelli, M., Paolini, M. et al. Neonatal screening for 21-hydroxylase deficiency: a microfilter paper method for 17-α-hydroxyprogesterone assay. J Endocrinol Invest 5, 87–90 (1982). https://doi.org/10.1007/BF03350496